Building a Peptide Practice

Peptide therapy can be incorporated into a clinical practice through several business models, each with distinct advantages, limitations, and operational requirements. Choosing the right model — or combination of models — depends on the practitioner's existing practice structure, patient population, clinical expertise, regulatory environment, and financial goals. Understanding the range of options prevents practitioners from defaulting to a single model without appreciating the alternatives.

The concierge medicine / direct primary care (DPC) model: Patients pay a monthly or annual membership fee directly to the practice, bypassing insurance for the primary care relationship. The membership fee funds the practitioner's time, access, and care coordination — supplemental services (laboratory tests, specialist referrals, medications) may be additional costs. This model is particularly well-suited to peptide therapy because: the monthly membership creates a recurring revenue stream that supports the ongoing monitoring relationship required for most peptide therapies; it eliminates the billing complexity of insurance for services and therapies that insurers typically don't cover; and it attracts patients who are invested in their health optimization and willing to pay out-of-pocket for comprehensive care. Peptide therapy is natural extension of the DPC philosophy — individualized, proactive, science-driven care focused on optimization rather than disease management.

The integrated functional medicine model: A functional or integrative medicine practice adds peptide therapy as one service within a comprehensive wellness offering that may include nutritional medicine, hormone optimization, detoxification protocols, genomics, and other evidence-informed integrative modalities. The advantage of this model is that peptide therapy fits naturally within the integrative medicine philosophy and patient population, and the practice's existing patient base provides a ready population for peptide therapy services. The clinical breadth of functional medicine also allows practitioners to address the whole-person context (nutrition, lifestyle, other hormonal imbalances) that optimizes peptide therapy outcomes. Certification in functional medicine (IFM, A4M, etc.) is valuable for credentialing and marketing in this model.

Medical spa / wellness center model: Some peptide therapy practices operate within the aesthetic medicine or wellness spa setting, offering peptide therapy alongside aesthetic services (botulinum toxin, dermal fillers, laser treatments), IV nutrient therapy, and body composition services. The existing patient flow in medical spas creates natural cross-selling opportunities — aesthetic patients interested in anti-aging may be excellent candidates for GH secretagogue or GHK-Cu therapy; body composition-focused clients may benefit from GLP-1 agonist or AOD-9604 therapy. The brand alignment of "anti-aging" and "wellness optimization" fits the peptide therapy narrative well. Regulatory caution is warranted: the medical spa setting must maintain the same clinical standards as a traditional medical practice, with physician-led patient selection, monitoring, and management — state regulations on medical spa supervision vary considerably.